Skip to main content

Table 1 Study flow-chart (per chemotherapy cycle)

From: Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trial

 

Day-1

Day 1

Day 2

Day3

Day4

Day 5

Day 6

Tablets of Cocculine or placebo

Evening

Morning

Noon

Evening

Morning

Noon

Evening

Morning

   

Antiemetic treatment

2

2

2

2

2

2

     

Chemotherapy

P1 (TAC)

S2 + M3

 

S4 + P1

S4 + P1

 

S4 + P1

S4 + P1

   

Phone call

X*

 

X

      

X**

 

FLIE questionnaire

           

Patients diary

          

X

    

X

  

X

X

X

X

 
  1. Po: per os; IV: intraverious; P: Prednisolone; M: Methyprednisolone; S: Ondansetron.
  2. 1: 60 mg po (TAC only); 2: 8 mg IV; 3: 60mg IV; 4: 8 mg po; *: all patients; **: on patients’ request.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us